• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    LFW Photonics Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    KALA BIO, Inc. - Common Stock (NQ:KALA)

    0.4602 -0.0154 (-3.24%)
    Streaming Delayed Price Updated: 10:17 AM EDT, Sep 28, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 90,027
    Open 0.4635
    Bid (Size) 0.4560 (100)
    Ask (Size) 0.4644 (100)
    Prev. Close 0.4756
    Today's Range 0.4521 - 0.4738
    52wk Range 0.4648 - 123.00
    Shares Outstanding 7,432,925
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Kala Bio and Virotek Sign Letter of Intent with U.S. DNA Testing Platform to Resell Virotek's Suite of Genetic Testing Products
    Agreement would expand the companies' genetic testing collaboration beyond ophthalmology to a selected suite of genomic testing products through an additional U.S. reseller channel 
    From KALA BIO, Inc.
    Via GlobeNewswire
    News headline image
    KALA BIO Adds Healthcare Operator Yenvy Truong to Advisory Team
    Founder of The LSM Group to support KALA's growth across its existing business and potential acquisitions 
    From KALA BIO, Inc.
    Via GlobeNewswire

    Performance

    YTD
    -98.5%
    -98.5%
    1 Month
    -33.3%
    -33.3%
    3 Month
    -78.0%
    -78.0%
    6 Month
    -94.6%
    -94.6%
    1 Year
    -99.5%
    -99.5%

    More News

    Read More
    On Thursday, there are stocks with unusual volume. Let's take a look. ↗
    Via Chartmill
    News headline image
    Kala Bio and Virotek Finalize Definitive Agreement Establishing Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
    From KALA BIO, Inc.
    Via GlobeNewswire
    The trading volume of these stocks is deviating from the norm in today's session. ↗
    Via Chartmill
    Tuesday's session: gap up and gap down stocks ↗
    Via Chartmill
    News headline image
    Kala Bio and Virotek Announce Letter of Intent to Establish an Exclusive U.S. Distribution Partnership for Ophthalmology Genetic Testing Program
    From KALA BIO, Inc.
    Via GlobeNewswire
    InvestorNewsBreaks – KALA BIO, Inc. (NASDAQ: KALA) Implements 1-For-50 Reverse Stock Split
    Via Investor Brand Network
    Topics Artificial Intelligence
    News headline image
    KALA BIO Announces Reverse Stock Split
    From KALA BIO, Inc.
    Via GlobeNewswire
    News headline image
    Kala Bio Celebrates Trump Executive Order as Game-Changer for Psychedelic Medicine
    From KALA BIO, Inc.
    Via GlobeNewswire
    News headline image
    $9.1 Billion Mesenchymal Stem Cell Market by 2031 to be Focused on by New Senior Scientific Advisor for KALA BIO, Inc. (Nasdaq: KALA)
    Via Get News
    Topics Artificial Intelligence Intellectual Property
    Wondering what's happening in today's after-hours session? ↗
    Via Chartmill
    News headline image
    Kala Bio Engages Dr. Saeid Babaei as Senior Scientific Advisor to Evaluate Clinical Assets and Precision Development Opportunities
    From KALA BIO, Inc.
    Via GlobeNewswire
    News headline image
    Bionic Intelligence Research Agent Now Commercially Live for Secure, Scalable, Autonomous Solutions in Global Biotech and Pharma Industries: KALA BIO, Inc. (Nasdaq: KALA)
    Via Get News
    Topics Artificial Intelligence Intellectual Property
    News headline image
    KALA BIO Delivers Industry-Leading AI Infrastructure: Bionic Intelligence Research Agent Now Live
    From KALA BIO, Inc.
    Via GlobeNewswire
    News headline image
    $180 Billion AI Healthcare Emerging Sector Highlighted by Red Light Holland’s Researgency.ai Platform for Biotech & Pharmaceutical Industry: KALA BIO, Inc. (Nasdaq: KALA)
    Via Get News
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Red Light Holland Engages Kala Bio’s Researgency.AI Platform to Support Clinical Development of Filament’s Patented PEX010 Botanical Psilocybin Drug Candidate
    From KALA BIO, Inc.
    Via GlobeNewswire
    Which stocks have an unusual volume on Friday? ↗
    Via Chartmill
    Which stocks have an unusual volume on Thursday? ↗
    Via Chartmill
    These stocks are making the most noise in today's session. ↗
    Via Chartmill
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    Younet.ai Highlights Researgency.ai Collaboration with Kala Bio (KALA) as New "AutoResearch" Milestone Signals the Rise of Autonomous Research Agents
    Via Newsfile
    Topics Artificial Intelligence
    What's going on in today's pre-market session ↗
    Via Chartmill
    News headline image
    Why Did KALA Stock Surge 70% In Pre-Market Today? ↗
    Via Stocktwits
    Topics Artificial Intelligence
    News headline image
    Kala Bio Launches a Revolution for Biotech- First AI Agent Deploying in 14 Days as $180 Billion Agentic AI Healthcare Revolution Accelerates
    From KALA BIO, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is KALA BIO, Inc. - Common Stock publicly traded?
    Yes, KALA BIO, Inc. - Common Stock is publicly traded.
    What exchange does KALA BIO, Inc. - Common Stock trade on?
    KALA BIO, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for KALA BIO, Inc. - Common Stock?
    The ticker symbol for KALA BIO, Inc. - Common Stock is KALA on the Nasdaq Stock Market
    What is the current price of KALA BIO, Inc. - Common Stock?
    The current price of KALA BIO, Inc. - Common Stock is 0.4602
    When was KALA BIO, Inc. - Common Stock last traded?
    The last trade of KALA BIO, Inc. - Common Stock was at 09/28/26 10:17 AM ET
    What is the market capitalization of KALA BIO, Inc. - Common Stock?
    The market capitalization of KALA BIO, Inc. - Common Stock is 3.42M
    How many shares of KALA BIO, Inc. - Common Stock are outstanding?
    KALA BIO, Inc. - Common Stock has 3M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.